Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 102.40
Bid: 102.40
Ask: 102.60
Change: -0.20 (-0.19%)
Spread: 0.20 (0.195%)
Open: 103.00
High: 103.00
Low: 102.40
Prev. Close: 102.60
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hipgnosis Songs Fund announces debt refinancing

3 Oct 2022 07:00

RNS Number : 4551B
Hipgnosis Songs Fund Limited
03 October 2022
 

LEI: 213800XJIPNDVKXMOC11

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Hipgnosis Songs Fund announces debt refinancing 

3 October 2022

The Board of Hipgnosis Songs Fund Limited, the first UK listed investment company offering investors a pure-play exposure to songs and associated intellectual property rights, and its Investment Adviser, Hipgnosis Song Management Limited, are pleased to announce the successful refinancing of the Company's debt facilities. 

The Company has entered into a new Revolving Credit Facility (RCF) with a commitment of US$700 million which runs for five years until 30 September 2027. The facility will be used to refinance, in full, the Company's pre-existing RCF and for working capital purposes. In accordance with the Investment Policy, any borrowings by the Company will not exceed 30% of the value of the net assets of the Company.

Interest on the new facility charged is based on the Secured Overnight Financing Rate (SOFR), published by the New York Federal Reserve, plus a margin of between 2.00% and 2.25% depending on the gross drawn debt. The initial margin will be 2.00%.

In addition, the Company is in advanced talks to fix the majority of its interest rate exposure by entering into interest rate swaps to hedge the interest on the Company's drawn debt. The Company expects the completion of this transaction shortly and will update the market in due course.

City National Bank was lead arranger and sole bookrunner for the new debt facility with Truist Securities, Inc., MUFG Union Bank, N.A. and Fifth Third Bank as co-leads.

As reported in the Company's Financial results, at 31 March 2022 the Company's gross debt was $600 million. The credit margin on this debt was 3.25% over a floating rate based on the London Interbank Offered Rate (LIBOR). Net debt as a percentage of Operative NAV at 31 March 2022 was 25.4%.

Merck Mercuriadis, CEO and Founder of Hipgnosis Song Management said:

"In an increasingly unpredictable debt market, this deal materially reduces our interest margin and the swaps we hope to close imminently provide long term certainty and a stable platform to take advantage of our industry's tailwinds.

"The continued growth in streaming and additional revenue streams from digital platforms, irrespective of macroeconomic conditions, coupled with the improved terms of our new RCF is very encouraging for SONG and will deliver value to our shareholders as income from our portfolio of songs increases."

Chris Helm, CFO (SONG) of Hipgnosis Song Management said: 

"Our new debt facility reduces the interest margin and provides added flexibility and headroom for the Company.

"This is a strong commitment from both our new and old lenders and we would like to thank them for their support."

Jim Irvin, Senior Vice President, City National Bank said: 

"We are extremely optimistic about Hipgnosis Songs Fund's growth and potential, which is why City National Bank is pleased to provide debt refinancing. The new revolving credit facility will reduce the margin on the company's debt at a time of interest rate volatility and ensure SONG delivers superior value for shareholders into the future."

For more information:

Hipgnosis Song Management

Merck Mercuriadis

Chris Helm

Giles Croot (Media)

Rufina Pavry (Investors)

 

 

 

+44 (0)20 4542 1511

+44 (0)20 4542 1530

Singer Capital Markets - Joint Corporate Broker

James Moat / James Maxwell / Alex Emslie (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

+44 (0)20 7496 3000

J.P. Morgan Cazenove - Joint Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

James Bouverat (Sales)

+44 (0)20 7742 4000

RBC Capital Markets - Joint Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

Lisa Tugwell / Anastasia Mikhailova (Sales)

+44 (0)20 7635 4000

Ocorian - Company Secretary & Administrator

Lorna Zimny

+44 (0) 28 9693 0222

FTI Consulting

Neil Doyle/ Paul Harris/ Laura Ewart

+44 (0)7771 978220; +44 (0)7809 411882; +44 (0)7761 332646

The Outside Organisation

Alan Edwards / Nick Caley

+44 (0)7711 081 843

All US music publicity enquiries

Fran Defeo

+1 917 767 5255

Notes to Editors

About Hipgnosis Songs Fund

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. The Company has raised a total of almost £1.3 billion (gross equity capital) through its Initial Public Offering on 11 July 2018, and subsequent issues in April 2019, August 2019, October 2019, July 2020, September 2020, February 2021 and July 2021. In September 2019, Hipgnosis transferred its entire issued share capital to the Premium listing segment of the Official List of the FCA and to the London Stock Exchange's Premium segment of the Main Market, and in March 2020 became a constituent of the FTSE 250 Index. Since April 2021, the Company has been resident in the UK for tax purposes and is recognised as an investment trust under applicable HMRC regulations. 

About Hipgnosis Song Management Limited

The Hipgnosis Songs Fund's Investment Adviser is Hipgnosis Song Management Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc. The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of Hipgnosis Song Management Limited Advisory Board include Nile Rodgers, The-Dream, Giorgio Tuinfort, Starrah, David A. Stewart, Poo Bear, Bill Leibowitz, Ian Montone and Rodney Jerkins.

About City National Bank

With $91.2 billion in assets, City National Bank provides banking, investment and trust services through 68 branches, including 22 full-service regional centers, in Southern California, the San Francisco Bay Area, Nevada, New York City, Nashville, Atlanta, Washington, D.C. and Miami*. In addition, the company and its investment affiliates manage or administer $83.0 billion in client investment assets. City National is a subsidiary of Royal Bank of Canada (RBC), one of the world's leading diversified financial services companies. RBC serves more than 17 million personal, business, public sector and institutional clients through offices in Canada, the United States and 27 other countries. For more information about City National, visit the company's website at cnb.com.

*City National Bank does business in Miami and the state of Florida as CN Bank.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRDZMGGGZVGZZZ
Date   Source Headline
30th Mar 20207:00 amRNSAcquisition of Music Catalogue
25th Mar 202012:03 pmRNSPrice Monitoring Extension
23rd Mar 20205:03 pmRNSDirector/PDMR Shareholding
19th Mar 20201:56 pmRNSDirector/PDMR Shareholding
18th Mar 20202:18 pmRNSDirector/PDMR Shareholding
17th Mar 202011:36 amRNSInvestment Adviser Purchase of Shares
16th Mar 20204:04 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSFTSE 250 Index Inclusion
2nd Mar 20207:00 amRNSTotal Voting Rights
26th Feb 20207:00 amRNSContemplation of Equity Raise and USD Quote
14th Feb 202011:52 amRNSDirectors' Share Holdings
7th Feb 20205:30 pmRNSHipgnosis Songs Fund
7th Feb 20207:00 amRNSNAV's, C Share Conversion and Total Voting Rights
3rd Feb 20207:00 amRNSTotal Voting Rights
24th Jan 20207:00 amRNSAcquisition of Music Catalogue
23rd Jan 20207:00 amRNSDividend Declaration
17th Jan 20207:00 amRNSAcquisition of Music Catalogue
13th Jan 20207:00 amRNSConversion of C Shares
9th Jan 20207:00 amRNSAcquisition of Music Catalogue
7th Jan 20207:00 amRNSAcquisition of Music Catalogue
30th Dec 20197:00 amRNSPerformance Fee and Total Voting Rights
20th Dec 20197:00 amRNSAcquisition of Music Catalogue
18th Dec 20197:00 amRNSAcquisition of Music Catalogue
17th Dec 20197:00 amRNSAcquisition of Music Catalogue
16th Dec 20193:11 pmRNSDirector/PDMR Shareholding
12th Dec 20197:00 amRNSAcquisition of Music Catalogue
11th Dec 20197:01 amRNSAcquisition of Music Catalogue
11th Dec 20197:00 amRNSInterim Results
10th Dec 20197:00 amRNSAcquisition of Music Catalogue
9th Dec 20194:47 pmRNSInvestor Call on 12 December 2019
3rd Dec 20197:00 amRNSAcquisition of Music Catalogue
27th Nov 20197:00 amRNSAppointment of Non-Executive Director
25th Nov 20197:00 amRNSNet Asset Value and Notice of Results
19th Nov 20199:00 amRNSLSE Welcomes Hipgnosis to Premium Segment
1st Nov 20197:00 amRNSTotal Voting Rights
24th Oct 20194:16 pmRNSHolding(s) in Company
24th Oct 20197:00 amRNSInterim Dividend Declaration
23rd Oct 20194:45 pmRNSHolding(s) in Company
23rd Oct 20194:44 pmRNSHolding(s) in Company
22nd Oct 20195:22 pmRNSDirector/PDMR Shareholding
17th Oct 201911:18 amRNSResult of Extraordinary General Meeting
17th Oct 20197:00 amRNSResult of C Share Issue
16th Oct 20197:00 amRNSAcquisition of Music Catalogue
9th Oct 20195:48 pmRNSDirector/PDMR Shareholding - Replacement
9th Oct 20194:59 pmRNSDirector/PDMR Shareholding
8th Oct 20194:45 pmRNSHolding(s) in Company
8th Oct 20193:33 pmRNSHolding(s) in Company
8th Oct 20191:22 pmRNSHolding(s) in Company
27th Sep 201912:28 pmRNSPublication of Prospectus
27th Sep 20197:00 amRNSInitial Placing & Offer of C Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.